Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Mu Zi LIANG"'
Autor:
Mu Zi Liang, Peng Chen, M. Tish Knobf, Alex Molassiotis, Ying Tang, Guang Yun Hu, Zhe Sun, Yuan Liang Yu, Zeng Jie Ye
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
ObjectiveThe application of advanced Cognitive Diagnosis Models (CDMs) in the Patient Reported Outcome (PRO) is limited due to its complex statistics. This study was designed to measure resilience using CDMs and its prediction of 6-month Quality of L
Externí odkaz:
https://doaj.org/article/d1058d5e54ea4b9cb84b5022d10a2a84
Autor:
Mu Zi Liang, Ying Tang, Peng Chen, Jian Liang, Zhe Sun, Guang Yun Hu, Yuan Liang Yu, Zeng Jie Ye
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-10 (2021)
Abstract Objective Resilience instruments specific to family caregivers (FCs) in cancer are limited. This study was designed to validate the 10-item Resilience Scale Specific to Cancer (RS-SC-10) in FCs using multidimensional item response theory (MI
Externí odkaz:
https://doaj.org/article/8b7b5c81a0ff4129b91a41c88e98f751
Autor:
Zeng Jie Ye, Zhang Zhang, Ying Tang, Jian Liang, Xiao Ying Zhang, Guang Yun Hu, Zhe Sun, Mu Zi Liang, Yuan Liang Yu
Publikováno v:
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-10 (2020)
Abstract Background The minimum clinical important differences (MCIDs) of resilience instruments in patients with cancer have not been comprehensively described. This study was designed to evaluate MCIDs of 10-item and 25-item resilience scales speci
Externí odkaz:
https://doaj.org/article/3af56dfcb71f4873a21acd25ca8cd759
Autor:
Mu Zi Liang1, Peng Chen2, Ying Tang3, Xiao Na Tang4, Molassiotis, Alex5, Knobf, M. Tish6, Mei Ling Liu7, Guang Yun Hu8, Zhe Sun9, Yuan Liang Yu10, Zeng Jie Ye11 zengjieye@qq.com
Publikováno v:
Depression & Anxiety (1091-4269). 5/17/2024, Vol. 2024, p1-11. 11p.
Autor:
Mu Zi LIANG, Ying TANG, M. Tish Knobf, Alex Molassiotis, Peng CHEN, Guang Yun HU, Zhe SUN, Yuan Liang YU, Zeng Jie YE
Publikováno v:
Journal of Cancer Survivorship. 17:759-768
Autor:
Yuan Liang Yu, Zhang Zhang, Zeng Jie Ye, Zhe Sun, Ying Tang, Mu Zi Liang, Jian Liang, Guang Yun Hu
Publikováno v:
Psycho-oncologyREFERENCE. 30(6)
Objective Be Resilient to Breast Cancer (BRBC), a theoretically-derived, resilience-based, culturally-tailored, supportive-expressive group therapy (SEGT), has been developed to help promote patients' resilience in breast cancer. Data from patients r
Autor:
Yuan Liang Yu, Zhang Zhang, Guang Yun Hu, Zhe Sun, Zeng Jie Ye, Jian Liang, Xiao Ying Zhang, Ying Tang, Mu Zi Liang
Publikováno v:
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-10 (2020)
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-10 (2020)
Background The minimum clinical important differences (MCIDs) of resilience instruments in patients with cancer have not been comprehensively described. This study was designed to evaluate MCIDs of 10-item and 25-item resilience scales specific to ca
Autor:
Mu Zi Liang, Ying Tang, Zeng Jie Ye, Yuan Liang Yu, Xiao Ying Zhang, Jian Liang, Meng Hui Cheng, Zhe Sun
Publikováno v:
Cancer nursing. 44(3)
Background The treatment-related decision-making process is a highly emotional time for parents of children with incurable cancer, and they tend to continue the cancer-directed treatment even when they realize that there is no cure for their child. O
Autor:
Peng Chen, Hong Zhong Qiu, Peng Fei Li, Shu Ni Wang, Guang Yun Hu, Zeng Jie Ye, Zhe Sun, Yuan Liang Yu, Mu Zi Liang
Publikováno v:
Quality of Life Research. 27:355-365
Resilience is an important concept in the cancer literature and is a salient indicator of cancer survivorship. The aim of this study is to develop and validate a new resilience instrument that is specific to patients with cancer diagnosis (RS-SC) in
Autor:
Guang Yun Hu, Shu Ni Wang, Yun Fei Zhu, Peng Fei Li, Mei Ling Liu, Yuan Liang Yu, Zhang Zhang, Jing Jing Zhao, Peng Chen, Hui Huang, Hong Zhong Qiu, Kun Lun Liao, Qu Hu, Cai Fen Peng, Mu Zi Liang, Zhe Sun, Zhen Zeng, Zeng Jie Ye
Publikováno v:
British Journal of Cancer
Background: Because of medical advances, metastatic breast cancer (MBC) is now viewed as a chronic disease, rather than an imminent death sentence. Helping women live with this disease requires more than a medical approach to symptoms. Thus, a mentor